Small interfering RNA targeting ILK inhibits EMT in human peritoneal mesothelial cells through phosphorylation of GSK-3β

Molecular Medicine Reports

Volumn 10, Issue 1, 2014, Pages 137-144

  Luo, Lingrong ^a   Liu, Hong ^a   Dong, Zheng ^b   Sun, Lin ^a   Peng, Youming ^a   Liu, Fuyou ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Epithelial mesenchymal transition; Glycogen synthase kinase 3 ; Human peritoneal mesothelial cells; Integrin linked kinase; Peritoneal dialysis

Indexed keywords

COLLAGEN TYPE 1; CYCLIN D1; FIBRONECTIN; GLUCOSE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; GLYCOGEN SYNTHASE KINASE 3BETA; INTEGRIN LINKED KINASE; MESSENGER RNA; SMALL INTERFERING RNA; UVOMORULIN; VIMENTIN; CADHERIN; GLYCOGEN SYNTHASE KINASE 3; INTEGRIN-LINKED KINASE; PROTEIN SERINE THREONINE KINASE;

ARTICLE; CELL MEMBRANE; CELL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; DOSE RESPONSE; ENZYME INHIBITION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MESOTHELIUM CELL; PERITONEAL FIBROSIS; PERITONEAL MESOTHELIAL CELL; PERITONEUM CELL; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; UPREGULATION; ANTAGONISTS AND INHIBITORS; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; EPITHELIUM CELL; GENETICS; METABOLISM; PERITONEUM; PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

CADHERINS; CELLS, CULTURED; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; GLUCOSE; GLYCOGEN SYNTHASE KINASE 3; HUMANS; PERITONEUM; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84901474602     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2014.2162     Document Type: Article

References (57)

1. Aroeira LS, Aguilera A, Selgas R, et al: Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. Am J Kidney Dis 46: 938-948, 2005. (Pubitemid 41505470)
2. Yáñez-Mó M, Lara-Pezzi E, Selgas R, et al: Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells. N Engl J Med 348: 403-413, 2003. (Pubitemid 36159357)
3. Kim YL: Update on mechanisms of ultrafiltration failure. Perit Dial Int 29 (Suppl 2): S123-S127, 2009.
4. Loureiro J, Aguilera A, Selgas R, et al: Blocking TGF-β1 protects the peritoneal membrane from dialysate-induced damage. J Am Soc Nephrol 22: 1682-1695, 2011.
5. Margetts PJ, Bonniaud P, Liu L, et al: Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 16: 425-436, 2005. (Pubitemid 41725138)
6. Vargha R, Endemann M, Kratochwill K, et al: Ex vivo reversal of in vivo transdifferentiation in mesothelial cells grown from peritoneal dialysate effluents. Nephrol Dial Transplant 21: 2943-2947, 2006. (Pubitemid 44542254)
7. Wang X, Nie J, Jia Z, et al: Impaired TGF-beta signalling enhances peritoneal inflammation induced by E. coli in rats. Nephrol Dial Transplant 25: 399-412, 2010.
8. Lee HB and Ha H: Mechanisms of epithelial-mesenchymal transition of peritoneal mesothelial cells during peritoneal dialysis. J Korean Med Sci 22: 943-945, 2007.
9. Zeisberg M and Duffield JS: Resolved: EMT produces fibroblasts in the kidney. J Am Soc Nephrol 21: 1247-1253, 2010.
10. Liu Y: New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 21: 212-222, 2010.
11. Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, Coppolino MG, Radeva G, Filmus J, Bell JC and Dedhar S: Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase. Nature 379: 91-96, 1996. (Pubitemid 26008142)
12. Legate KR, Montañez E, Kudlacek O and Fässler R: ILK, PINCH and parvin: the tIPP of integrin signaling. Nat Rev Mol Cell Biol 7: 20-31, 2006. (Pubitemid 43361569)
13. Dai HY, Zheng M, Lv LL, Tang RN, Ma KL, Liu D, Wu M and Liu BC: The roles of connective tissue growth factor and integrin-linked kinase in high glucose-induced phenotypic alterations of podocytes. J Cell Biochem 113: 293-301, 2012.
14. Li Y, Tan X, Dai C, Stolz DB, Wang D and Liu Y: Inhibition of integrin-linked kinase attenuates renal interstitial fibrosis. J Am Soc Nephrol 20: 1907-1918, 2009.
15. Teixeira Vde P, Blattner SM, Li M, et al: Functional consequences of integrin-linked kinase activation in podocyte damage. Kidney Int 67: 514-523, 2005. (Pubitemid 40139843)
16. Kretzler M, Teixeira VP, Unschuld PG, et al: Integrin-linked kinase as a candidate downstream effector in proteinuria. FASEB J 15: 1843-1845, 2001.
17. Guo L, Sanders PW, Woods A and Wu C: The distribution and regulation of integrin-linked kinase in normal and diabetic kidneys. Am J Pathol 159: 1735-1742, 2001. (Pubitemid 33062516)
18. Li Y, Yang J, Dai C, et al: Role for integrin-linked kinase in mediating tubular epithelial to mesenchymal transition and renal interstitial fibrogenesis. J Clin Invest 112: 503-516, 2003. (Pubitemid 38056335)
19. Persad S, Attwell S, Gray V, Mawji N, Deng JT, Leung D, et al: Regulation of protein kinase B/Akt-serine 473 phosphorylation by integrin-linked kinase: critical roles for kinaseactivity and amino acids arginine 211 and serine 343. J Biol Chem 276: 27462-27469, 2001.
20. Delcommenne M, Tan C, Gray V, Rue L, Woodgett J and Dedhar S: Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA 95: 11211-11216, 1998. (Pubitemid 28450107)
21. Vi L, de Lasa C, DiGuglielmo GM, et al: Integrin-linked kinase is required for TGF-β1 induction of dermal myofibroblast differentiation. J Invest Dermatol 131: 586-593, 2011.
22. Li Y, Yang J, Luo JH, et al: Tubular epithelial cell dedifferentiation is driven by the helix-loop-helix transcriptional inhibitor Id1. J Am Soc Nephrol 18: 449-460, 2007. (Pubitemid 46193311)
23. Smeeton J, Zhang X, Bulus N, et al: Integrin-linked kinase regulates p38 MAPK-dependent cell cycle arrest in ureteric bud development. Development 137: 3233-3243, 2010.
24. Liu XC, Liu BC, Zhang XL, et al: Role of ERK1/2 and PI3-K in the regulation of CTGF-induced ILK expression in HK-2 cells. Clin Chim Acta 382: 89-94, 2007.
25. Stylianou E, Jenner LA, Davies M, Coles GA and Williams JD: Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 37: 1563-1570, 1990. (Pubitemid 20198041)
26. Rougier JP, Moullier P, Piedagnel R and Ronco PM: Hyperosmolality suppresses but TGF beta 1 increases MMP9 in human peritoneal mesothelial cells. Kidney Int 51: 337-347, 1997. (Pubitemid 27064556)
27. Blattner SM and Kretzler M: Integrin-linked kinase in renal disease: connecting cell-matrix interaction to the cytoskeleton. Curr Opin Nephrol Hypertens 14: 404-410, 2005. (Pubitemid 40863081)
28. Dai C, Stolz DB, Bastacky SI, St-Arnaud R, Wu C, Dedhar S and Liu Y: Essential role of integrin-linked kinase in podocyte biology: Bridging the integrin and slit diaphragm signaling. J Am Soc Nephrol 17: 2164-2175, 2006. (Pubitemid 44141906)
29. Kang YS, Li Y, Dai C, Kiss LP, Wu C and Liu Y: Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kidney Int 78: 363-373, 2010.
30. Li Y, Dai C, Wu C and Liu Y: PINCH-1 promotes tubular epithelial-to-mesenchymal transition by interacting with integrin-linked kinase. J Am Soc Nephrol 18: 2534-2543, 2007. (Pubitemid 47378870)
31. Hu K, Wu C, Mars WM and Liu Y: Tissue-type plasminogen activator promotes murine myofibroblast activation through LDL receptor-related protein 1-mediated integrin signaling. J Clin Invest 117: 3821-3832, 2007. (Pubitemid 350224092)
32. Guo L and Wu C: Regulation of fibronectin matrix deposition and cell proliferation by the PINCH-ILK-CH-ILKBP complex. FASEB J 16: 1298-1300, 2002.
33. Tu Y, Huang Y, Zhang Y, Hua Y and Wu C: A new focal adhesion protein that interacts with integrin-linked kinase and regulates cell adhesion and spreading. J Cell Biol 153: 585-598, 2001. (Pubitemid 34280144)
34. Nikolopoulos SN and Turner CE: Molecular dissection of actopaxin-integrin-linked kinase-Paxillin interactions and their role in subcellular localization. J Biol Chem 277: 1568-1575, 2002. (Pubitemid 34968915)
35. Troussard AA, Costello P, Yoganathan TN, Kumagai S, Roskelley CD and Dedhar S: The integrin linked kinase (ILK) induces an invasive phenotype via AP-1 transcription factor-dependent upregulation of matrix metalloproteinase 9 (MMP-9). Oncogene 19: 5444-5452, 2000. (Pubitemid 32000911)
36. D'Amico M, Hulit J, Amanatullah DF, et al: The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways. J Biol Chem 275: 32649-32657, 2000.
37. Joshi MB, Ivanov D, Philippova M, Erne P and Resink TJ: Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3beta in endothelial cells. FASEB J 21: 3083-3095, 2007. (Pubitemid 47565529)
38. Sellin JH, Umar S, Xiao J and Morris AP: Increased beta-catenin expression and nuclear translocation accompany cellular hyperproliferation in vivo. Cancer Res 61: 2899-2906, 2001. (Pubitemid 32691932)
39. Yang Y, Guo L, Blattner SM, Mundel P, Kretzler M and Wu C: Formation and phosphorylation of the PINCH-1-integrin linked kinase-alpha-parvin complex are important for regulation of renal glomerular podocyte adhesion, architecture, and survival. J Am Soc Nephrol 16: 1966-1976, 2005. (Pubitemid 41716427)
40. Cortés JC, Montalvo EA, Muñiz J, Mornet D, Garrido E, Centeno F and Cisneros B: Dp71f modulates GSK3-beta recruitment to the beta1-integrin adhesion complex. Neurochem Res 34: 438-444, 2009.
41. Kalra J, Sutherland BW, Stratford AL, et al: Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1. Oncogene 29: 6343-6356, 2010.
42. del Nogal M, Luengo A, Olmos G, Lasa M, Rodriguez-Puyol D, Rodriguez-Puyol M and Calleros L: Balance between apoptosis or survival induced by changes in extracellular-matrix composition in human mesangial cells: a key role for ILK-NfκB pathway. Apoptosis 17: 1261-1274, 2012.
43. Papachristou DJ, Gkretsi V, Rao UN, et al: Expression of integrin-linked kinase and its binding partners in chondrosarcoma: association with prognostic significance. Eur J Cancer 44: 2518-2525, 2008.
44. McDonald PC, Fielding AB and Dedhar S: Integrin-linked kinase - essential roles in physiology and cancer biology. J Cell Sci 121: 3121-3132, 2008.
45. Fielding AB, Dobreva I, McDonald PC, Foster LJ and Dedhar S: Integrin-linked kinase localizes to the centrosome and regulates mitotic spindle organization. J Cell Biol 180: 681-689, 2008. (Pubitemid 351397766)
46. Shin SY, Rath O, Zebisch A, Choo SM, Kolch W and Cho KH: Functional roles of multiple feedback loops in extracellular signal-regulated kinase and Wnt signaling pathways that reg-ulate epithelial-mesenchymal transition. Cancer Res 70: 6715-6724, 2010.
47. Acloque H, Thiery JP and Nieto MA: The physiology and pathology of the EMT. Meeting on the epithelial-mesenchymal transition. EMBO Rep 9: 322-326, 2008.
48. Xing Y, Qi J, Deng S, Wang C, Zhang L and Chen J: Small interfering RNA targeting ILK inhibits metastasis in human tongue cancer cells through repression of epithelial-to-mesenchymal transition. Exp Cell Res 319: 2058-2072, 2013.
49. McDonald PC, Oloumi A, Mills J, et al: Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival. Cancer Res 68: 1618-1624, 2008. (Pubitemid 351416544)
50. Doble BW and Woodgett JR: Role of glycogen synthase kinase-3 in cell fate and epithelial-mesenchymal transitions. Cells Tissues Organs 185: 73-84, 2007. (Pubitemid 46956846)
51. McPhee TR, McDonald PC, Oloumi A and Dedhar S: Integrin-linked kinase regulates E-cadherin expression through PARP-1. Dev Dyn 237: 2737-2747, 2008.
52. Maseki S, Ijichi K, Tanaka H, et al: Acquisition of EMT phenotype in the gefitinib-resistant cells of a head and neck squamous cell carcinoma cell line through Akt/GSK-3β/snail signalling pathway. Br J Cancer 106: 1196-1204, 2012.
53. Wu C and Dedhar S: Integrin-linked kinase (ILK) and its interactors: a new paradigm for the coupling of extracellular matrix to actin cytoskeleton and signaling complexes. J Cell Biol 155: 505-510, 2001. (Pubitemid 34289309)
54. Radeva G, Petrocelli T, Behrend E, Leung-Hagesteijn C, Filmus J, Slingerland J and Dedhar S: Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression. J Biol Chem 272: 13937-13944, 1997. (Pubitemid 27224838)
55. Tan C, Costello P, Sanghera J, Dominguez D, Baulida J, de Herreros AG and Dedhar S: Inhibition of integrin linked kinase (ILK) suppresses beta-catenin-Lef/Tcf-dependent transcription and expression of the E-cadherin repressor, snail, in APC-/- human colon carcinoma cells. Oncogene 20: 133-140, 2001. (Pubitemid 32142346)
56. Barisoni L, Mokrzycki M, Sablay L, Nagata M, Yamase H and Mundel P: Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int 58: 137-143, 2000. (Pubitemid 30429858)
57. Petermann AT, Pippin J, Hiromura K, et al: Mitotic cell cycle proteins increase in podocytes despite lack of proliferation. Kidney Int 63: 113-122, 2003. (Pubitemid 35463912)